Literature DB >> 12845265

Serum inhibin B levels reflect contralateral testicular damage following unilateral testicular trauma.

Keramettin Uğur Ozkan1, Mustafa Kücükaydin, Sabahattin Muhtaroğlu, Olgun Kontaş, Fahri Karaca.   

Abstract

INTRODUCTION: The aim of this study was to evaluate contralateral testicular damage (CTD) following unilateral blunt testicular trauma (BTT) and testicular capsule laceration (TCL) by the serum inhibin B level which is an accepted marker of spermatogenesis.
METHODS: Fifty peripubertal male Wistar albino rats were divided into 5 groups each containing 10 rats. Group 1 was the control group. Group 2 was the BTT group in which the right testicle was placed on a firm surface and a metal rod weighing 215 g was dropped onto the testicle from a height of 5.5 cm. Group 3 was the TCL group in which right testicular tunica albuginea was lacerated using the needle of 4/0 silk suture. Group 4 had right orchiectomy initially. Group 5 was the sham group. In all groups, 3-ml blood samples were taken and bilateral orchiectomies were performed 6 weeks after initial manipulations.
RESULTS: Groups 2 and 3 had decreased inhibin B levels (p < 0.001), although the orchiectomy group had normal levels. Histological analyses showed lower Johnsen scores for both trauma groups in the ipsilateral and contralateral testes (p < 0.05).
CONCLUSIONS: Serum inhibin B levels decrease following unilateral testicular trauma reflecting CTD. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845265     DOI: 10.1159/000071098

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  1 in total

1.  Effects of bilateral efferent duct ligation on sperm motility and secretion of FSH, LH, inhibin, and testosterone in adult male rats.

Authors:  Longquan Ren; Mohamed S Medan; Chunmei Li; Qiang Weng; Maiko Kawaguchi; Gen Watanabe; Kazuyoshi Taya
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.